We are live on ! Find out more
ELV icon

Elevance Health

1,422 hedge funds and large institutions have $106B invested in Elevance Health in 2022 Q1 according to their latest regulatory filings, with 150 funds opening new positions, 524 increasing their positions, 488 reducing their positions, and 93 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more first-time investments, than exits

New positions opened: 150 | Existing positions closed: 93

29% more funds holding in top 10

Funds holding in top 10: 52 → 67 (+15)

3% more funds holding

Funds holding: 1,375 → 1,422 (+47)

7% more repeat investments, than reductions

Existing positions increased: 524 | Existing positions reduced: 488

3% more capital inflows, than outflows

Capital inflows: $5.14B | Capital outflows: $5B

0.63% more ownership

Funds ownership: 88.68% → 89.31% (+0.63%)

7% less call options, than puts

Call options by funds: $433M | Put options by funds: $466M

Holders
1,422
Holders Change
+47
Holders Change %
+3.42%
% of All Funds
22.34%
Holding in Top 10
67
Holding in Top 10 Change
+15
Holding in Top 10 Change %
+28.85%
% of All Funds
1.05%
New
150
Increased
524
Reduced
488
Closed
93
Calls
$433​M
Puts
$466​M
Net Calls
-⁠$33.1​M
Net Calls Change
+$81.1​M

ELV Hedge Fund Activity: Q1 2022 in Review

1,422 of the 6,366 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q1 2022, worth a combined $106B — up 6% from $100B a quarter earlier.

Buyers outnumbered sellers: 150 funds opened new ELV positions and 93 closed out — a net gain of 57 holders — while 524 added to existing stakes and 488 trimmed.

The largest buyer was Vanguard Group, adding an estimated $850M. The largest seller was T. Rowe Price Associates, cutting an estimated $479M.

  • 1,422 institutional investors held Elevance Health (ELV) as of Q1 2022, up from 1,375 in Q4 2021.
  • Funds reported $106B of Elevance Health stock for Q1 2022, up 6% quarter-over-quarter.
  • 150 funds opened new Elevance Health positions in Q1 2022 and 93 closed out, a net change of +57 holders.
  • The largest Elevance Health buyer in Q1 2022 was Vanguard Group, an estimated $850M added.
  • The largest Elevance Health seller in Q1 2022 was T. Rowe Price Associates, an estimated $479M sold.

Based on aggregated 13F filings for Q1 2022.